6882

Xiamen Amoytop Biotech Co., Ltd.SHSE:688278 Stock Report

Market Cap CN¥34.7b
Share Price
CN¥85.30
My Fair Value
CN¥77
10.4% overvalued intrinsic discount
1Y55.1%
7D-0.4%
Portfolio Value
​
View

Xiamen Amoytop Biotech Co., Ltd.

SHSE:688278 Stock Report

Market Cap: CN¥34.7b

Xiamen Amoytop Biotech (688278) Stock Overview

Engages in research, development, production, and sale of recombinant protein drugs in China. More details

688278 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth6/6
Past Performance5/6
Financial Health6/6
Dividends3/6

Rewards

Trading at 48.3% below our estimate of its fair value

Earnings are forecast to grow 29.41% per year

Earnings grew by 44.6% over the past year

Risk Analysis

High level of non-cash earnings


688278 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Xiamen Amoytop Biotech Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Xiamen Amoytop Biotech
Historical stock prices
Current Share PriceCN¥85.30
52 Week HighCN¥93.52
52 Week LowCN¥53.36
Beta-0.29
1 Month Change12.28%
3 Month Change14.37%
1 Year Change55.06%
3 Year Change198.25%
5 Year Change60.55%
Change since IPO141.64%

Recent News & Updates

Recent updates

With EPS Growth And More, Xiamen Amoytop Biotech (SHSE:688278) Makes An Interesting Case

Mar 17
With EPS Growth And More, Xiamen Amoytop Biotech (SHSE:688278) Makes An Interesting Case

Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 26% Jump Shows Its Popularity With Investors

Sep 19
Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 26% Jump Shows Its Popularity With Investors

Investors Appear Satisfied With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Prospects As Shares Rocket 26%

Sep 19
Investors Appear Satisfied With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Prospects As Shares Rocket 26%

Shareholder Returns

688278CN BiotechsCN Market
7D-0.4%2.3%3.9%
1Y55.1%38.3%48.2%

Return vs Industry: 688278 exceeded the CN Biotechs industry which returned 35.8% over the past year.

Return vs Market: 688278 exceeded the CN Market which returned 46% over the past year.

Price Volatility

Is 688278's price volatile compared to industry and market?
688278 volatility
688278 Average Weekly Movement5.5%
Biotechs Industry Average Movement5.9%
Market Average Movement4.9%
10% most volatile stocks in CN Market8.6%
10% least volatile stocks in CN Market2.8%

Stable Share Price: 688278 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 688278's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19962,423Li Sunwww.amoytop.com

Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of recombinant protein drugs in China. The company provides solutions for diseases, such as viral hepatitis, malignant tumors, and immunotherapy. Xiamen Amoytop Biotech Co., Ltd.

Xiamen Amoytop Biotech Co., Ltd. Fundamentals Summary

How do Xiamen Amoytop Biotech's earnings and revenue compare to its market cap?
688278 fundamental statistics
Market capCN¥34.70b
Earnings (TTM)CN¥951.15m
Revenue (TTM)CN¥3.14b
36.5x
P/E Ratio
11.1x
P/S Ratio

Is 688278 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688278 income statement (TTM)
RevenueCN¥3.14b
Cost of RevenueCN¥209.75m
Gross ProfitCN¥2.93b
Other ExpensesCN¥1.98b
EarningsCN¥951.15m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)2.34
Gross Margin93.32%
Net Profit Margin30.31%
Debt/Equity Ratio0.4%

How did 688278 perform over the long term?

See historical performance and comparison

Dividends

0.7%
Current Dividend Yield
27%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/22 17:22
End of Day Share Price 2025/08/22 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Xiamen Amoytop Biotech Co., Ltd. is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hao WuChasing Securities
Pei ChengChina Galaxy Securities Co., Ltd.
Sophia ZhangChina Stock Investment Research Co. Ltd. (GZ500..com)